Framework for the Provision of Dose Banded Products & Patient Specific Chemotherapy Services
In plain English
The notice doesn't say
Who holds it now
Last won by Rosemont Pharmaceuticals Ltd and Prulab Pharma Ltd and Vertical Pharma Resources Ltd and 2 more in Oct 2026, for £1m.
- Framework for the supply of Unlicensed Specials.Rosemont Pharmaceuticals Ltd, Prulab Pharma Ltd, Vertical Pharma Resources Ltd and 2 more £1m
- Framework for the supply of Ready to Administer ProductsB Braun Ltd, Baxter Healthcare Ltd, ITH Pharma Ltd and 3 more £6.4m
- Famework Agreement for the Supply of Ready to Administer ProductsHameln Pharma Ltd, Fresenius Kabi Limited £3.2m
What you're up against
- The last two awards went to different firms: this buyer has changed supplier before.
- 13 different firms won this buyer's 3 awards for this kind of work since 2025.
- It last went for £1m in 2026.
- The last award named 5 suppliers: it may be a framework, where many firms are chosen.
The notice as published
The East Midlands Pharmacy Collaborative (EMPC) as the Authority wishes to establish a multi-provider Framework Agreement for its members the Dose Banded Products & Patient Specific Chemotherapy Services as defined in this specification. This procurement exercise is being carried out as an Open Procedure under the PA23 Regulations. The Framework will run for an initial 2 Year period with an option to extend for a further 2 Years. (2 + 2 - maximum duration 4 Years) This a new PME notice published due to changes in the Procurement Timetable. The previous notice was published on 12th May 2025 under 2025/S 000-020394.